SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950123-01-503167
Filing Date
2001-06-01
Accepted
2001-06-01 00:00:00
Documents
4
Group Members
PHARMACIA & UPJOHN COMPANYPHARMACIA & UPJOHN HOLDINGS BVPHARMACIA & UPJOHN SPAPHARMACIA & UPJOHN, INC.PHARMACIA ABPHARMACIA CORP /DE/PHARMACIA TREASURY SERVICES AB

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #4 TO SCHEDULE 13D y49873sc13da.txt SC 13D/A 71802
2 LETTER AGREEMENT: AMENDING ORIG WARRANT AGREEMENT y49873ex99-d.txt EX-99.D 4207
3 LETTER AGREEMENT: AMENDING ORIG REG RIGHTS AGREE y49873ex99-f.txt EX-99.F 3214
4 SUBLEASE ASSIGNMENT y49873ex99-j.txt EX-99.J 4923
  Complete submission text file 0000950123-01-503167.txt   87104
Mailing Address 100 ROUTE 206 NORTH PEAPACK NJ 07977
Business Address 100 ROUTE 206 NORTH PEAPACK NJ 07977 9089018000
PHARMACIA CORP /DE/ (Filed by) CIK: 0000067686 (see all company filings)

IRS No.: 430420020 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2800 Chemicals & Allied Products

Mailing Address 336 BOLLAY DRIVE SANTA BARBARA CA 93117
Business Address 336 BOLLAY DRIVE SANTA BARBARA CA 93117 8056859880
MIRAVANT MEDICAL TECHNOLOGIES (Subject) CIK: 0000933745 (see all company filings)

IRS No.: 770222872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-49175 | Film No.: 1652980
SIC: 2834 Pharmaceutical Preparations